Extract from the Register of European Patents

Citations: EP2889033

Cited inSearch
Type:Patent literature
Publication No.:WO03055878  [AD]
 (BAYER AG [DE], et al) [AD] 1-8 * page 19, line 1 - page 20, line 4 * * page 26, lines 1-3 * * example 69 * * claims 12-15 *;
Type:Non-patent literature
Publication information:[A]  - ACKER BRAD A ET AL, "Discovery of N-[(3R,5R)-1-azabicyclo[3.2.1]oct-3-yl]furo[2,3-c]pyridi ne-5-carboxamide as an agonist of the alpha 7 nicotinic acetylcholine receptor: In vitro and in vivo activity", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (200806), vol. 18, no. 12, ISSN 0960-894X, pages 3611 - 3615, XP002572658 [A] 1-8 * abstract * * page 3611, column 1, paragraph 1 - column 2, paragraph 1 *
DOI: http://dx.doi.org/10.1016/j.bmcl.2008.04.070
Type:Non-patent literature
Publication information:[A]  - WISHKA DONN G ET AL, "Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine- 5-carboxamide, an agonist of the alpha 7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: Synthesis and structure-activity relationship", JOURNAL OF MEDICINAL CHEMISTRY, (200607), vol. 49, no. 14, ISSN 0022-2623, pages 4425 - 4436, XP002572659 [A] 1-8 * abstract * * page 4425, column 1, paragraph 1 - column 2, paragraph 1 * * table 1 * * page 4428, column 2, paragraph 3 - page 4429, column 1, paragraph 2 *
DOI: http://dx.doi.org/10.1021/jm0602413
Type:Non-patent literature
Publication information:[A]  - GRAY J A ET AL, "The pipeline and future of drug development in schizophrenia.", MOLECULAR PSYCHIATRY OCT 2007, (200710), vol. 12, no. 10, ISSN 1359-4184, pages 904 - 922, XP002572660 [A] 1-8 * abstract * * page 905, column 1, paragraph 5 - column 2, paragraph 4 * * see alpha nAChR, and PNU 282987 in Table 1; page 907, lines 11-14 * * table 3 * * page 913, column 1, paragraph 4 - column 2, paragraph 1 *
DOI: http://dx.doi.org/10.1038/sj.mp.4002062
Type:Non-patent literature
Publication information:[A]  - FREEDMAN ROBERT ET AL, "Initial Phase 2 Trial of a Nicotinic Agonist in Schizophrenia", AMERICAN JOURNAL OF PSYCHIATRY, (200808), vol. 165, no. 8, doi:10.1176/appi.ajp.2008.07071135, ISSN 0002-953X, pages 1040 - 1047, XP055182228 [A] 1-8 * abstract * * tables 1-2 *
DOI: http://dx.doi.org/10.1176/appi.ajp.2008.07071135
Cited inby applicant
Type:Patent literature
Publication No.:WO03055878  
Type:Non-patent literature
Publication information:   - ADLER, L.E.; HOFFER, L.D.; WISER, A.; FREEDMAN, R., "Normalization of auditory physiology by cigarette smoking in schizophrenic patients", AM J PSYCHIATRY, (1993), vol. 150, pages 1856 - 1861, XP001062599
Type:Non-patent literature
Publication information:   - ADLER, L.E.; OLINCY, A.; WALDO, M.; HARRIS, J.G.; GRIFFITH, J.; STEVENS, K.; FLACH, K.; NAGAMOTO, H.; BICKFORD, P.; LEONARD, S., "Schizophrenia, sensory gating, and nicotinic receptors", SCHIZOPHR BULL, (1998), vol. 24, pages 189 - 202
Type:Non-patent literature
Publication information:   - BALDEWEG, T.; WONG, D.; STEPHAN, K.E., "Nicotinic modulation of human auditory sensory memory: Evidence from mismatch negativity potentials", INT J PSYCHOPHYSIOL, (2006), vol. 59, doi:doi:10.1016/j.ijpsycho.2005.07.014, pages 49 - 58, XP024954070
DOI: http://dx.doi.org/10.1016/j.ijpsycho.2005.07.014
Type:Non-patent literature
Publication information:   - BOUTROS, N.N.; OVERALL, J.; ZOURIDAKIS, G., "Test-retest reliability of the P50 mid-latency auditory evoked response", PSYCHIATRY RES, (1991), vol. 39, pages 181 - 192
Type:Non-patent literature
Publication information:   - DALEBOUT, S.D.; FOX, L.G., "Reliability of the mismatch negativity in the responses of individual listeners", J AM ACAD AUDIOL, (2001), vol. 12, pages 245 - 253
Type:Non-patent literature
Publication information:   - DE WILDE, O.M.; BOUR, L.J.; DINGEMANS, P.M.; KOELMAN, J.H.; LINSZEN, D.H., "A meta-analysis of P50 studies in patients with schizophrenia and relatives: differences in methodology between research groups", SCHIZOPHR RES, (2007), vol. 97, doi:doi:10.1016/j.schres.2007.04.028, pages 137 - 151, XP022344543
DOI: http://dx.doi.org/10.1016/j.schres.2007.04.028
Type:Non-patent literature
Publication information:   - DIERKS, T.; FROLICH, L.; IHL, R.; MAURER, K., "Event-related potentials and psychopharmacology. Cholinergic modulation ofP300", PHARMAEOPSYCHIATRY, (1994), vol. 27, pages 72 - 74
Type:Non-patent literature
Publication information:   - DUNBAR, G.; BOEIJINGA, P.H.; DEMAZIERES, A.; CISTERNI, C.; KUCHIBHATLA, R.; WESNES, K.; LUTHRINGER, R., "Effects ofTC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers", PSYCHOPHARMACOLOGY (BERL, (2007), vol. 191, doi:doi:10.1007/s00213-006-0675-x, pages 919 - 929, XP019488596
DOI: http://dx.doi.org/10.1007/s00213-006-0675-x
Type:Non-patent literature
Publication information:   - DUNCAN, E.; MADONICK, S.; CHAKRAVORTY, S.; PARWANI, A.; SZILAGYI, S.; EFFEREN, T.; GONZENBACH, S.; ANGRIST, B.; ROTROSEN, J, "Effects of smoking on acoustic startle and prepulse inhibition in humans", PSYCHOPHARMACOLOGY (BERL, (2001), vol. 156, pages 266 - 272
Type:Non-patent literature
Publication information:   - EASTON, C.J.; BAUER, L.O., "Beneficial effects of thiamine on recognition memory and P300 in abstinent cocaine-dependent patients", PSYCHIATRY RES, (1997), vol. 70, pages 165 - 174
Type:Non-patent literature
Publication information:   - FREEDMAN, R.; LEONARD, S.; GAULT, J.M.; HOPKINS, J.; CLONINGER, C.R.; KAUFMANN, C.A.; TSUANG, M.T.; FARONE, S.V.; MALASPINA, D.; S, "Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7", AM J MED GENET, (2001), vol. 105, pages 20 - 22
Type:Non-patent literature
Publication information:   - FUERST, D.R.; GALLINAT, J.; BOUTROS, N.N., "Range of sensory gating values and test-retest reliability in normal subjects", PSYCHOPHYSIOLOGY, (2007), vol. 44, pages 620 - 626
Type:Non-patent literature
Publication information:   - HEINRICHS, R.W., "Meta-analysis and the science of schizophrenia: variant evidence or evidence of variants?", NEUROSCI BIOBEHAV REV, (2004), vol. 28, pages 379 - 394
Type:Non-patent literature
Publication information:   - KAGA, K.; HARRISON, J.B.; BUTCHER, L.L.; WOOLF, N.J.; BUCHWALD, J.S., "Cat 'P300' and cholinergic septohippocampal neurons: depth recordings, lesions, and choline acetyltransferase immunohistochemistry", NEUROSCI RES, (1992), vol. 13, doi:doi:10.1016/0168-0102(92)90034-A, pages 53 - 71, XP024336835
DOI: http://dx.doi.org/10.1016/0168-0102(92)90034-A
Type:Non-patent literature
Publication information:   - KATADA, E.; SATO, K.; SAWAKI, A.; DOHI, Y.; UEDA, R.; OJIKA, K., "Long-term effects of donepezil on P300 auditory event-related potentials in patients with Alzheimer's disease", J GERIATR PSYCHIATRY NEUROL, (2003), vol. 16, pages 39 - 43
Type:Non-patent literature
Publication information:   - MAURER, T.; DEBARTOLO, D.; TESS, D.; SCOTT, D., "The relationship between the exposure and non-specific binding of thirty-three central nervous system drugs in mice", DRUG METABOLISM AND DISPOSITION, (2005), vol. 33, pages 175 - 181
Type:Non-patent literature
Publication information:   - NAATANEN, R.; ALHO, K., "Generators of electrical and magnetic mismatch responses in humans", BRAIN TOPOGR, (1995), vol. 7, pages 315 - 320
Type:Non-patent literature
Publication information:   - OLINCY, A.; HARRIS, J.G.; JOHNSON, L.L.; PENDER, V.; KONGS, S.; ALLENSWORTH, D.; ELLIS, J.; ZERBE, G.O.; LEONARD, S.; STEVENS, K.E, "Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia", ARCH GEN PSYCHIATRY, (2006), vol. 63, pages 630 - 638, XP009130792
Type:Non-patent literature
Publication information:   - POTTER, D.; SUMMERFELT, A.; GOLD, J.; BUCHANAN, R.W., "Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia", SCHIZOPHR BULL, (2006), vol. 32, pages 692 - 700
Type:Non-patent literature
Publication information:   - SANDMAN, C.A.; PATTERSON, J.V., "The auditory event-related potential is a stable and reliable measure in elderly subjects over a 3 year period", CLIN NEUROPHYSIOL, (2000), vol. 111, doi:doi:10.1016/S1388-2457(00)00320-5, pages 1427 - 1437, XP085045508
DOI: http://dx.doi.org/10.1016/S1388-2457(00)00320-5
Type:Non-patent literature
Publication information:   - SCHALL, U.; JOHNSTON, P.; TODD, J.; WARD, P.B.; MICHIE, P.T., "Functional neuroanatomy of auditory mismatch processing: an event-related fMRI study of duration-deviant oddballs", NEUROIMAGE, (2003), vol. 20, pages 729 - 736
Type:Non-patent literature
Publication information:   - TRAINOR, G, "The importance of plasma protein binding in drug discovery", EXPERT OPINION IN DRUG DISCOVERY, (2007), vol. 2, doi:doi:10.1517/17460441.2.1.51, pages 51 - 64, XP055325244
DOI: http://dx.doi.org/10.1517/17460441.2.1.51
Type:Non-patent literature
Publication information:   - TURETSKY, B.I.; CALKINS, M.E.; LIGHT, G.A.; OLINCY, A.; RADANT, A.D.; SWERDLOW, N.R., "Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures", SCHIZOPHR BULL, (2007), vol. 33, pages 69 - 94
Type:Non-patent literature
Publication information:   - UMBRICHT, D.; KRLJES, S., "Mismatch negativity in schizophrenia: a meta-analysis", SCHIZOPHR RES, (2005), vol. 76, doi:doi:10.1016/j.schres.2004.12.002, pages 1 - 23, XP025357445
DOI: http://dx.doi.org/10.1016/j.schres.2004.12.002
Type:Non-patent literature
Publication information:   - WERBER, A.E.; KLEIN, C.; RABEY, J.M., "Evaluation of cholinergic treatment in demented patients by P300 evoked related potentials", NEUROL NEUROCHIR POL, (2001), vol. 35, no. 3, pages 37 - 43